Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1

Clinical trial NCT07128212 · COMPLETED

Trial details

NCT number: NCT07128212
Sponsor: Suzhou Municipal Hospital of Anhui Province
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Ischemic White Matter Lesions (WMIL)Cerebral Small Vessel Disease Vascular Cell Adhesion Molecule-1 VCAM-1

Start date: 2021-01-01
Primary completion: 2022-12-31
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.